ContextVision Webcast Q1 2021
Progress in establishing reference centers within digital pathology
Investor presentation ContextVision – Interview with Nordnet
Nordnet have published an investor presentation of ContextVision. Please find the interview with CEO Fredrik Palm below (in Norwegian/Swedish) or follow this link.
ContextVision Webcast Q2 2019
ContextVision – Second quarter saw commercial release of first AI-based product, Altumira™, Digital Pathology on track and record sales
Company presentation held at Carnegie in Stockholm
Stockholm, June 12th, 2019 – Today ContextVision held a company presentation at Carnegie in Stockholm, Sweden. Fredrik Palm gave an update of the company’s development and shared the company’s future direction. Please find a PDF-version of the presentation here. For further information, please contact ContextVision’s CEO, Fredrik Palm, at +46 76 870 25 43 or […]
ContextVision Webcast Q1 2019
ContextVision on track for 2019 commercial product launch within digital pathology
ContextVision Earns Acclaim from Frost & Sullivan for Its AI-powered INIFY™ Prostate Cancer Screening Platform
Based on its recent analysis of the European prostate cancer screening market, Frost & Sullivan recognises the Stockholm-based ContextVision AB with the 2019 European Technology Leadership Award for its INIFY™ Prostate platform.
Lovende svar i ContextVision studie – appearance in the Norwegian business newspaper Finansavisen
March 11st, 2019 – An article about ContextVision has been published in the Norwegian business newspaper Finansavisen (in Norwegian only). Please find a link here. For further information, please contact ContextVision’s CEO, Fredrik Palm, at +46 76 870 25 43
ContextVision skapar nya lösningar med hjälp av AI – appearance in online magazine Investeringstipset
An update on ContextVision has been published in the Swedish online magazine Investeringstipset.
ContextVision Webcast Q4 2018
ContextVision on track for 2019 commercial product launch within digital pathology
ContextVision Webcast Q3 2018
ContextVision – Strong Q3 sales and positive feedback within digital pathology
- 1
- 2